Published in Int J Oncol on May 03, 2011
Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Sci Signal (2012) 1.95
A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One (2012) 1.07
Melanoma Development and Progression Are Associated with Rad6 Upregulation and β -Catenin Relocation to the Cell Membrane. J Skin Cancer (2014) 0.82
Activation of the canonical Wnt/β-catenin signalling pathway is rare in canine malignant melanoma tissue and cell lines. J Comp Pathol (2012) 0.81
β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour. Vet Comp Oncol (2013) 0.78
The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines. Oncotarget (2016) 0.77
Upregulation of the cytoskeletal-associated protein Moesin in the neointima of coronary arteries after balloon angioplasty: a new marker of smooth muscle cell migration? Cardiovasc Res (2002) 1.52
Identification of novel sense and antisense transcription at the TRPM2 locus in cancer. Cell Res (2008) 1.15
High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma. Cancer Sci (2008) 1.09
p38MAPK mediates IL-1-induced down-regulation of aggrecan gene expression in human chondrocytes. Int J Mol Med (2006) 1.03
ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer (2011) 0.90
MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma. Eur J Cancer (2010) 0.88
Functional implication of truncated P-cadherin expression in malignant melanoma. Exp Mol Pathol (2006) 0.86
E-cadherin cell-cell communication in melanogenesis and during development of malignant melanoma. Arch Biochem Biophys (2011) 0.85
Heterogeneous transition metal-based fluorescence polarization (HTFP) assay for probing protein interactions. Biotechniques (2009) 0.84
Targeting melanoma metastasis and immunosuppression with a new mode of melanoma inhibitory activity (MIA) protein inhibition. PLoS One (2012) 0.83
Foxa2 (HNF-3beta) regulates expression of hepatotrophic factor ALR in liver cells. Biochem Biophys Res Commun (2010) 0.82
Loss of p14ARF expression in melanoma. Arch Dermatol Res (2002) 0.81
A potential predictive marker for response to interferon in malignant melanoma. J Dtsch Dermatol Ges (2007) 0.81
Melanoma inhibitory activity in melanoma diagnostics and therapy - a small protein is looming large. Exp Dermatol (2014) 0.78
Pitfalls in immunohistochemistry--a recent example. Int J Clin Exp Pathol (2012) 0.76
Melanoma sponge on pigmentation gene to reduce tumour-suppressive microRNAs. Pigment Cell Melanoma Res (2017) 0.75